Description:CP 673451 is a small molecule that acts as a selective inhibitor of certain receptor tyrosine kinases, particularly those involved in the signaling pathways of cancer cell proliferation and survival. It is primarily studied for its potential therapeutic applications in oncology, particularly in targeting tumors that exhibit aberrant signaling through these kinases. The compound is characterized by its ability to interfere with the ATP-binding site of the target kinases, thereby inhibiting their activity and downstream signaling cascades. CP 673451 has shown promise in preclinical studies, demonstrating efficacy in various cancer models. Its chemical structure includes specific functional groups that contribute to its binding affinity and selectivity. As with many investigational drugs, the pharmacokinetics, metabolism, and safety profile of CP 673451 are critical areas of research, as they determine its viability for clinical use. Ongoing studies aim to elucidate its full therapeutic potential and any associated side effects in the context of cancer treatment.
We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.
![1 - (2 - (5 - (2-Methoxyethoxy) - 1H-Benzo [D] Imidazol-1-Yl) Quinoline-8-Yl) Piperidin-4-Amine](https://static.cymitquimica.com/products/54/thumb/OR1023799.jpg)
